Healthcare provider profile · identity verified

Jie Wu, MD

Internal Medicine · EL PASO, TX · NPI 1356501209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	953	301
Levothyroxine Sodium	Levothyroxine Sodium	882	237
Losartan Potassium	Losartan Potassium	552	162
Metformin Hcl	Metformin Hcl	520	163
Lisinopril	Lisinopril	501	156
Amlodipine Besylate	Amlodipine Besylate	442	133
Simvastatin	Simvastatin	419	122
Pravastatin Sodium	Pravastatin Sodium	370	112
Alendronate Sodium	Alendronate Sodium	357	102
Omeprazole	Omeprazole	275	87
Hydrochlorothiazide	Hydrochlorothiazide	267	83
Gabapentin	Gabapentin	243	90
Glimepiride	Glimepiride	241	76
Montelukast Sodium	Montelukast Sodium	215	68
Tramadol Hcl	Tramadol Hcl	213	38
Alprazolam	Alprazolam	192	37
Metformin Hcl Er	Metformin Hcl	180	54
Pantoprazole Sodium	Pantoprazole Sodium	180	63
Rosuvastatin Calcium	Rosuvastatin Calcium	162	45
Escitalopram Oxalate	Escitalopram Oxalate	139	51
Metoprolol Succinate	Metoprolol Succinate	139	49
Vitamin D2	Ergocalciferol (Vitamin D2)	137	42
Carvedilol	Carvedilol	121	39
Januvia	Sitagliptin Phosphate	119	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	113	36
Glipizide	Glipizide	110	34
Trazodone Hcl	Trazodone Hcl	109	37
Pioglitazone Hcl	Pioglitazone Hcl	108	32
Ezetimibe	Ezetimibe	107	30
Tamsulosin Hcl	Tamsulosin Hcl	99	37
Tizanidine Hcl	Tizanidine Hcl	98	38
Allopurinol	Allopurinol	96	32
Ozempic	Semaglutide	95	29
Famotidine	Famotidine	94	37
Metoprolol Tartrate	Metoprolol Tartrate	93	31
Sertraline Hcl	Sertraline Hcl	91	34
Duloxetine Hcl	Duloxetine Hcl	89	31
Fluticasone Propionate	Fluticasone Propionate	88	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	24
Albuterol Sulfate Hfa	Albuterol Sulfate	84	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	11
Synthroid	Levothyroxine Sodium	81	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	27
Zolpidem Tartrate	Zolpidem Tartrate	68	16
Hydralazine Hcl	Hydralazine Hcl	65	21
Ibandronate Sodium	Ibandronate Sodium	64	21
Clonazepam	Clonazepam	62	13
Clopidogrel	Clopidogrel Bisulfate	60	20
Prolia	Denosumab	60	37
Citalopram Hbr	Citalopram Hydrobromide	59	18
Furosemide	Furosemide	55	24
Acetaminophen-Codeine	Acetaminophen With Codeine	50	suppressed
Nifedipine Er	Nifedipine	47	12
Benazepril Hcl	Benazepril Hcl	44	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	44	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	18
Memantine Hcl	Memantine Hcl	41	16
Buspirone Hcl	Buspirone Hcl	40	13
Fenofibrate	Fenofibrate Nanocrystallized	38	13
Potassium Chloride	Potassium Chloride	38	12
Olmesartan Medoxomil	Olmesartan Medoxomil	37	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	37	11
Ibuprofen	Ibuprofen	36	14
Jardiance	Empagliflozin	36	16
Donepezil Hcl	Donepezil Hcl	35	14
Telmisartan	Telmisartan	35	11
Esomeprazole Magnesium	Esomeprazole Magnesium	34	11
Finasteride	Finasteride	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Spironolactone	Spironolactone	31	12
Triamcinolone Acetonide	Triamcinolone Acetonide	31	18
Chlorthalidone	Chlorthalidone	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	18
Trulicity	Dulaglutide	30	suppressed
Valsartan	Valsartan	29	suppressed
Atenolol	Atenolol	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	11
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	12
Mupirocin	Mupirocin	25	suppressed
Baclofen	Baclofen	24	14
Fenofibrate	Fenofibrate,micronized	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	11
Eliquis	Apixaban	23	suppressed
Lactulose	Lactulose	23	11
Nystatin	Nystatin	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ramipril	Ramipril	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Ursodiol	Ursodiol	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Lorazepam	Lorazepam	17	suppressed
Meloxicam	Meloxicam	16	suppressed
Nateglinide	Nateglinide	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Buprenorphine	Buprenorphine	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error